Table S3 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial
Year: 2024
Type: other
Abstract: Table S3 shows Adverse Events Included in the Co-Primary Endpoint: All Occurrences
Authors: Channing J. Paller, Marianna L. Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth Heath, William K. Kelly, Christopher Hoimes, Pedro Barata, Jason Taksey, Dominique A. Garrison, Kartick Patra, Ginger L. Milne, Nicole M. Anders, Julie M. Nauroth, Jennifer N. Durham, Catherine H. Marshall, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Michael A. Carducci, Samuel R. Denmeade, Mark Levine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402159161
